Can people develop sickle cell disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sickle Cell Disease is Inherited, Not Acquired

People cannot "develop" or "get" sickle cell disease during their lifetime—it is exclusively an inherited genetic disorder present from birth. 1, 2

Genetic Inheritance Pattern

  • Sickle cell disease is an autosomal recessive genetic disorder that requires inheriting abnormal hemoglobin genes from both parents. 1

  • The disease results from a specific genetic mutation: a C to A substitution at codon 6 of the beta globin gene, replacing glutamic acid with valine, creating abnormal hemoglobin S (HbS). 2

  • Infants with SCD are healthy at birth and only develop symptoms early in infancy or childhood as fetal hemoglobin levels decline. 1

How People Have Sickle Cell Disease

  • You must be born with it—specifically inheriting the sickle hemoglobin gene from both parents (homozygous HbSS) or inheriting HbS from one parent and another abnormal hemoglobin variant from the other parent (compound heterozygous states like HbSC or HbS-β-thalassemia). 1

  • All 50 U.S. states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and the U.S. military have newborn screening programs capable of making a definitive diagnosis of SCD at birth. 1

  • Approximately 300,000 infants are born annually worldwide with SCD, with most living in sub-Saharan Africa, India, the Mediterranean, and Middle East; approximately 100,000 individuals with SCD live in the U.S. 3

Critical Distinction: Sickle Cell Trait vs. Disease

  • The heterozygous carrier state (HbAS or sickle cell trait) is generally benign and represents having one normal hemoglobin gene and one sickle hemoglobin gene. 2, 4

  • Sickle cell trait is fundamentally different from sickle cell disease and is described as a "mostly benign condition" that only becomes clinically important at extremes of physiology such as severe sepsis, prolonged hypoxia, or severe dehydration. 4

  • The approximately 240,000 healthy carriers with sickle cell trait in the UK do not require the specialized management needed for patients with actual sickle cell disease. 4

Common Pitfall to Avoid

Do not confuse "being diagnosed with" sickle cell disease with "developing" it. While diagnosis may occur at various ages (particularly for children born outside countries with newborn screening programs), the genetic condition has been present since conception. 1 The disease is diagnosed through newborn screening programs where available, or when patients present with unexplained severe atraumatic pain or normocytic anemia. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sickle Cell Disease Pathophysiology and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sickle Cell Trait Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is sickle cell disease and how is it managed in patients of African, Mediterranean, or Middle Eastern descent with a history of anemia, infections, and organ damage?
What is sickle cell disease?
Is sickle cell disease a form of cancer?
What is the pathophysiology of sickle cell anemia?
What is sickle cell anemia?
What is the recommended treatment for a patient with a Corynebacterium striatum urinary tract infection (UTI)?
Can a cardiologist interpret Doppler measurements of diastolic filling, including an E/A (E-to-A wave ratio) ratio of 0.69, MV (mitral valve) E' tissue velocity lateral of 9.8 cm/s, MV E' tissue velocity medial of 6.5 cm/s, and an E wave deceleration time of 236 msec, in a patient with potential impaired renal function, indicated by elevated Cystatin C levels, and likely underlying cardiovascular risk factors such as hypertension or diabetes?
Is Trileptal (oxcarbazepine) a suitable treatment option for a patient with a history of self-harm behaviors and psychiatric comorbidities, potentially with borderline personality disorder?
What is the appropriate management plan for a newborn male with Hepatitis C (HCV) positivity, chronic liver disease, mild ascites, cholecystitis, cholelithiasis, anemia, thrombocytopenia, and elevated liver enzymes?
What are the expected signs of healing for a healthy adult abdominoplasty patient's incision site 10 days post-operative (post-op), considering possible comorbidities such as smoking or significant weight loss?
What is the appropriate management for a patient with a 2cm cervical lymph node having a thick hypoechoic cortex?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.